We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Automated Device Designed for Blood Group Serology

By LabMedica International staff writers
Posted on 21 Jul 2010
Print article
Routine blood typing and other interrelated tests can be performed on a fully automated, high-throughput system. The instrument is adaptable for any immunohematology procedure and easily connected to the host system, with compliant software and intelligent robotics.

The flexible system allows the operator to perform the following tests: blood grouping, reverse grouping, phenotyping, crossmatching, antibody screening, antibody identification, and direct antiglobulin tests.

The IH-1000 system has the capacity to stock reagent supplies of 240 ID-Cards, 28 vials of test cells and diluents as required. The instrument processes without restocking of reagents for an average of six to nine hours, depending on the test profile chosen. The appliance automatically shows the level of the reagent supplies and additional reagents can be introduced at any time. The status of the supplies is checked by the device itself or from a remote location, for example from a Wi-Fi connection.

Bio-Rad Laboratories, Inc., (Hercules, CA, USA) manufactures the IH-1000 which offers integrated quality control and validation, intuitive software, and walk-away convenience for blood banking laboratories. The IH 1000, designed for the blood transfusion laboratory, utilizes the industry accepted gold standard ID-System gel card technology. The instrument has two independent pipetting stations, three centrifuges, and an arm dedicated solely to card transport. There are automated maintenance steps; automatic tube diameter detection and tube decap checks. The machine has a built in integrated back-up system, with pipettors and centrifuges that compensate each other.

John Goetz, Bio-Rad Vice President said, "Our customers who have already worked with the IH 1000 during our testing phase have said the system delivers the highest level of automation as well as improved workflow advantages, without sacrificing the quality of the result."

Related Links:

Bio-Rad Laboratories, Inc


New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
ACTH Assay
ACTH ELISA
New
Aspergillus Test
REALQUALITY Aspergillus

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.